Allergan Aesthetics launched AA Signature in the United States on 22 Sept. 2026, introducing AA Signature: SKIN360 as the first multimodal consultation approach in the series.
The initiative is described as a collection of patient-centric, multimodal consultation approaches that leverage Allergan Medical Institute resources and Allergan Aesthetics products.
AA Signature: SKIN360 is tailored for patients seeking smoother, more hydrated skin and features SKINVIVE by JUVÉDERM, SkinMedica HA5 Hydra Collagen Hydrator with Vegan Collagen, and BOTOX Cosmetic (onabotulinumtoxinA).
The company claims the program includes provider education and resources and cites research findings that 96% of patients are interested in comprehensive assessments, that practices using multimodal planning see 68% higher patient retention, and that eight in 10 patients proceed with treatment after comprehensive assessments.
Allergan Aesthetics plans additional consultation protocols through 2027 addressing lift, structure, skin firmness, and facial definition, and notes that the safety and efficacy of combined use of the featured products have not been studied.
